Inspections and Audits

Dr. Reddy’s Nailed Again for Facility Slipups

Dr. Reddy’s inspection woes continue following the FDA’s inspection of its Indian API manufacturing plant in Bollaram, Hyderabad, which revealed multiple violations and netted the pharma giant yet another Form 483. Read More